TrademarkIQ íconeTrademarkIQ
Voltar para busca
Dado oficial do USPTO

ALYVANT

Sabia que essa marca já está registrada no Estados Unidos?

Antes de investir em nome, identidade e divulgação, valide risco de colisão e estratégia de registro para não perder tempo nem budget.

Active USPTO registrationTipo: VerbalEscritório: US

Snapshot rápido

ALYVANT

ST13

US500000079255282

Classe

9, 35, 41, 42, 44

Pedido

79255282

Registro

6087589

Diagnóstico de risco e oportunidade

Leitura executiva para decisão de naming, protocolo e monitoramento.

Atenção: há risco ativo

Situação USPTO

Active USPTO registration

Tipo de processo

Pedido e registro

Eventos registrados

34

Atualização mais recente

01/07/2025

Classificação

Registrada

Tipo de marca

Verbal

Classes Nice

9, 35, 41, 42, 44

Data de depósito

17/07/2018

Data de registro

30/06/2020

Data de expiração

-

Ação recomendada

Execute uma análise de colidência completa e valide classes antes de qualquer protocolo ou investimento de marca.

Próximo passo

Esses são os detalhes do processo de registro. Mesmo assim, o monitoramento constante é o que garante tranquilidade de que o seu principal ativo continue protegido.

Dados completos do processo

Campos estruturados da autoridade responsável e do histórico oficial.

Data da situação

30/06/2020

Última transação

01/07/2025

Escritório responsável

United States Patent and Trademark Office

Código da situação

700

Cadastro oficial

Principal Register

Código do desenho

4

Tipo de titular

27

Localização do titular

CH

Examinador

BURDECKI, ANNIE

Unidade examinadora

L80

Localização atual

PUBLICATION AND ISSUE SECTION

Titulares e representantes

Titulares

Roivant Sciences GmbH

Representantes

Allison Strickland Ricketts Fross Zelnick Lehrman & Zissu, P.C.

Classificação técnica

Classes Nice

Classe 9Classe 35Classe 41Classe 42Classe 44

Códigos Vienna

Sem códigos Vienna disponíveis.

Produtos e serviços

Classe 9

Computer software for providing, analyzing and generating reports; computer software for data processing; software and computer programs for the capture, collection, conversion, analysis, communication, processing, receiving, recording, storage and transmission of data, images and information; software and computer programs for the conversion, analysis, processing, storage and transmission of artificial intelligence; computer software for database integration; computer software for creating searchable databases of information and data; software for analyzing data in the fields of public health, healthcare, namely pharmaceutical commercialization, biomedical research and software for analyzing clinical trial data; downloadable computer software for use in management of databases featuring pharmaceutical and medical information; downloadable computer software for management of medical practices and research; downloadable computer search engine software for obtaining and providing updated scientific, medical and clinical information, and for obtaining and providing news of general interest related to disease awareness or pharmaceutical products; computer software for accessing data and information related to healthcare services and patient medical information, and for controlling and managing data and information related to healthcare services and patient medical information; downloadable computer software for measuring, monitoring, processing and tracking health, wellness and medical information

Classe 35

Advertising services related to pharmaceutical products; business management; business administration; business research and information services; market research and provision of information regarding market research; data processing services; analysis of business data; business data and statistical analysis, documentation being compilation of statistics and professional business consultancy services regarding statistics for biomedical research, namely, related to pharmaceutical commercialization, healthcare institutions and healthcare professionals, based on artificial intelligence and machine learning; business data analysis and statistical analysis of healthcare data, biomedical research and clinical trial data for business purposes to include pharmaceutical commercialization; systematization and compilation of data in computer databases; business research, market testing being market research and statistical analysis services for business purposes in the fields of public health, healthcare and biomedicine, namely, pharmaceutical commercialization and products, and for clinical trials; business advisory services, consultancy and information; advertising, marketing and sales promotion services for the pharmaceutical and medical products of others; providing business intelligence services in the fields of pharmaceuticals, public health and healthcare; providing an on-line database providing business intelligence in the fields of pharmaceuticals, public health and healthcare

Classe 41

Educational services, namely arranging, conducting and organizing classes, seminars, conferences, symposiums and training workshops in the field of healthcare and pharmaceuticals to promote the exchange of information and resources within the scientific research and medical communities to achieve advances in the fields of healthcare and pharmaceuticals, and distribution of training materials in connection therewith

Classe 42

Scientific and technological services, namely, research and design in the field of software for managing healthcare data; analysis of technical data by computers, being technical medical research in the field of healthcare, prescription and related data being carried out using computers; pharmaceutical and biomedical research services; scientific research in the field of pharmaceutical and biologic therapeutic preparations; pharmaceutical research and development; providing scientific research information in the field of pharmaceuticals and biomedicine; providing temporary use of online non-downloadable computer software for allowing users to connect to databases containing pharmaceutical and medical information; providing temporary use of online non-downloadable computer software for management of medical practices and research in connection with or related to pharmaceutical commercialization; providing temporary use of online non-downloadable computer search engine software for obtaining and providing updated scientific, medical and clinical information, and for obtaining and providing news of general interest; providing temporary use of online non-downloadable computer software for accessing data and information related to healthcare services and patient medical information, and for controlling and managing data and information related to healthcare services and patient medical information

Classe 44

Providing health and medical information to potential customers of pharmaceutical products; providing internet-based healthcare information in support of potential commercialization of pharmaceutical products for the treatment of diseases, disorders or conditions; providing information relating to the diagnostic, prophylactic and therapeutic properties of pharmaceutical preparations and biologic preparations for the prevention and treatment of diseases, disorders and conditions; medical services, namely, providing medical services and consultation related to pharmaceutical products or disease awareness over the telephone and via the Internet through the use of personal computers, smartphones, tablets, mobile and wireless devices, and other telecommunication devices; pharmaceutical advice; medical and pharmaceutical consultation related to pharmaceutical products or disease awareness; medical assistance in the nature of the provision of medical information, namely, information related to pharmaceutical products or disease awareness for medical professionals and potential patients from remote locations via the Internet and global computer networks through the use of a data storage and retrieval system

Publicações

Histórico de despachos e eventos da marca no USPTO.

34 publicações encontradas

REM3

COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED

30/06/2025

FINO

FINAL DECISION TRANSACTION PROCESSED BY IB

08/11/2020

FICS

FINAL DISPOSITION NOTICE SENT TO IB

20/10/2020

FIMP

FINAL DISPOSITION PROCESSED

20/10/2020

FICR

FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB

30/09/2020

R.PR

REGISTERED-PRINCIPAL REGISTER

30/06/2020

NPUB

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

14/04/2020

PUBO

PUBLISHED FOR OPPOSITION

14/04/2020

GPNX

NOTIFICATION PROCESSED BY IB

10/04/2020

OPNS

NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB

25/03/2020

OP2R

NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB

25/03/2020

NONP

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

25/03/2020

ALIE

ASSIGNED TO LIE

11/03/2020

CNSA

APPROVED FOR PUB - PRINCIPAL REGISTER

05/03/2020

TEME

TEAS/EMAIL CORRESPONDENCE ENTERED

03/03/2020

CRFA

CORRESPONDENCE RECEIVED IN LAW OFFICE

02/03/2020

ERFR

TEAS REQUEST FOR RECONSIDERATION RECEIVED

02/03/2020

GNFN

NOTIFICATION OF FINAL REFUSAL EMAILED

09/11/2019

GNFR

FINAL REFUSAL E-MAILED

09/11/2019

CNFR

FINAL REFUSAL WRITTEN

09/11/2019

TEME

TEAS/EMAIL CORRESPONDENCE ENTERED

09/10/2019

CRFA

CORRESPONDENCE RECEIVED IN LAW OFFICE

09/10/2019

TROA

TEAS RESPONSE TO OFFICE ACTION RECEIVED

09/10/2019

RFNP

REFUSAL PROCESSED BY IB

18/05/2019

NREP

NEW REPRESENTATIVE AT IB RECEIVED

17/05/2019

RFCS

NON-FINAL ACTION MAILED - REFUSAL SENT TO IB

02/05/2019

RFRR

REFUSAL PROCESSED BY MPU

02/05/2019

RFCR

NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW

10/04/2019

CNRT

NON-FINAL ACTION WRITTEN

09/04/2019

MAFR

APPLICATION FILING RECEIPT MAILED

05/04/2019

DOCK

ASSIGNED TO EXAMINER

01/04/2019

NWOS

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

01/04/2019

LIMI

LIMITATION FROM ORIGINAL APPLICATION ENTERED

29/03/2019

REPR

SN ASSIGNED FOR SECT 66A APPL FROM IB

28/03/2019

Proteção contínua da sua marca

Seja avisado a cada novo depósito que ameace ALYVANT ou a sua marca.

Vigilância profissional por 24 meses: monitoramos o USPTO por você e alertamos a tempo de você se opor — antes que o conflito vire prejuízo.